Introduction to Olaratumab Efficacy In Soft Tissue Sarcoma
If you are looking for information about Olaratumab Efficacy In Soft Tissue Sarcoma, you have come to the right place. Panelists William D. Tap, MD; Mark Agulnik, MD; Damon Reed, MD; Shreyaskumar Patel, MD; and George D. Demetri, MD, ...
Olaratumab Efficacy In Soft Tissue Sarcoma Comprehensive Overview
Anthony P. Conley, MD, reviews data for Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the William D. Tap, MD, chief,
Brian Van Tine, MD, PhD, assistant professor, Washington University School of Medicine, discusses the development of ...
Summary & Highlights for Olaratumab Efficacy In Soft Tissue Sarcoma
- Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the ...
- For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
- The panelists, Brian Van Tine, MD, PhD; Shreyaskumar Patel, MD; Robin L. Jones, MD, MRCP; Jonathan Trent, MD, PhD; and ...
- Ian Judson, MD, medical oncologist, The Royal Marsden Hospital, discusses the future role of
- William D. Tap, MD; Richard F. Riedel, MD; Victor M. Villalobos, MD, PhD; and Kristen N. Ganjoo, MD, comment on the overall ...
We hope this detailed breakdown of Olaratumab Efficacy In Soft Tissue Sarcoma was helpful.
